Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

132
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
132
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

507
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
507
Crossover Experiments01:16

Crossover Experiments

4.4K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.4K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

177
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
177
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

813
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
813
Study Design in Statistics01:15

Study Design in Statistics

9.9K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
9.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analytical Evaluation of the 2-in-1 Adaptive Design for Binary Endpoints.

Statistics in medicine·2026
Same author

Exact power and sample size in clinical trials with two co-primary binary endpoints.

Statistical methods in medical research·2025
Same author

Sample size calculation in clinical trials with two co-primary endpoints including overdispersed count and continuous outcomes.

Pharmaceutical statistics·2024
Same author

Nocturnal Hypertension and Left Ventricular Diastolic Dysfunction in Patients With Diabetes With the Absence of Heart Failure: Prospective Cohort HSCAA Study.

Hypertension (Dallas, Tex. : 1979)·2023
Same author

Efficacy and safety of the sodium-glucose co-transporter-2 inhibitor empagliflozin in elderly Japanese adults (≥65 years) with type 2 diabetes: A randomized, double-blind, placebo-controlled, 52-week clinical trial (EMPA-ELDERLY).

Diabetes, obesity & metabolism·2023
Same author

Usefulness of the placebo lead-in design for clinical trials with binary outcomes.

Clinical trials (London, England)·2023
Same journal

A Bayesian Optimal Interval Design Considering Efficacy and Toxicity in Early Phase Basket Trials.

Pharmaceutical statistics·2026
Same journal

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same journal

Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases.

Pharmaceutical statistics·2026
Same journal

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same journal

Optimizing Randomization Ratios in Clinical Trials With Survival Endpoints.

Pharmaceutical statistics·2026
Same journal

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: Jan 2, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.7K

Sequential parallel comparison design with two coprimary endpoints.

Gosuke Homma1, Takashi Daimon2

  • 1Graduate School of Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

Pharmaceutical Statistics
|December 13, 2019
PubMed
Summary
This summary is machine-generated.

New methods for sequential parallel comparison design (SPCD) trials with two coprimary endpoints in neurology improve hypothesis testing and sample size calculations. These advancements help detect true treatment effects despite high placebo response rates.

Keywords:
bivariate normally distributed endpointenrichment designintersection-union testplacebo nonresponderplacebo responder

More Related Videos

A Within-Subject Experimental Design using an Object Location Task in Rats
09:28

A Within-Subject Experimental Design using an Object Location Task in Rats

Published on: May 6, 2021

5.1K
Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

411

Related Experiment Videos

Last Updated: Jan 2, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.7K
A Within-Subject Experimental Design using an Object Location Task in Rats
09:28

A Within-Subject Experimental Design using an Object Location Task in Rats

Published on: May 6, 2021

5.1K
Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

411

Area of Science:

  • Clinical Trials Methodology
  • Neurology Research
  • Statistical Analysis in Medicine

Background:

  • Placebo-controlled randomized clinical trials (RCTs) are essential for demonstrating treatment efficacy, especially in neurology.
  • Neurological trials often require superiority over placebo on two coprimary endpoints, but high placebo response rates can obscure true treatment effects.
  • The sequential parallel comparison design (SPCD) is a potential solution for high placebo response rates, but its application with coprimary endpoints needs further development.

Purpose of the Study:

  • To develop a novel hypothesis-testing method for SPCD with two coprimary endpoints.
  • To create a corresponding sample size calculation method for SPCD trials with two coprimary endpoints.
  • To evaluate the performance of the proposed methods through simulations and a real-world case study.

Main Methods:

  • Development of a statistical hypothesis-testing framework tailored for SPCD with dual coprimary endpoints.
  • Formulation of a sample size calculation formula specifically for this SPCD design.
  • Monte Carlo simulations to assess type I error rate, power, and sample size accuracy.
  • Application of the developed methods to an existing SPCD trial for Alzheimer's disease-related agitation.

Main Results:

  • The proposed hypothesis-testing method effectively controls the type I error rate and achieves desired statistical power.
  • The sample size calculation method demonstrates adequate accuracy, ensuring appropriate participant numbers for trials.
  • Simulations confirmed the robustness of the developed statistical approaches.
  • The methods proved useful when applied to a real-world SPCD trial.

Conclusions:

  • The developed hypothesis-testing and sample size calculation methods are suitable for SPCD clinical trials involving two coprimary endpoints in neurology.
  • These statistical advancements can enhance the reliability of clinical trials by mitigating the impact of high placebo response rates.
  • The proposed methods offer a valuable tool for designing and analyzing future neurological studies aiming to demonstrate treatment superiority.